Clinical studies have shown that what percentage of patients may experience side effects from antiplatelet therapy?

In clinical studies, it has been observed that approximately 40% of patients undergoing antiplatelet therapy may experience side effects. This is significant because antiplatelet agents, while crucial for preventing thrombotic events such as heart attacks and strokes, can also lead to a variety of adverse effects, particularly gastrointestinal issues like bleeding, ulcers, and dyspepsia. The recognition of this percentage is essential for healthcare professionals as it highlights the need for careful monitoring of patients on these medications to manage potential complications effectively and enhance adherence to therapy. Understanding that 40% is a realistic expectation aids clinicians in counseling patients about the risks and benefits of antiplatelet therapy, ensuring that informed decisions can be made regarding their treatment plans.